SYDNEY HATTENDORF: Open Payments
NPI 1336788827 · OREGON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$290 in 6 payments from 6 companies in 2025. Trend: 2023 $330 · 2024 $560 · 2025 $290
Food & beverage: $290
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 1 | $125 |
| Janssen Biotech, Inc. | 1 | $89 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Madrigal Pharmaceuticals | 1 | $17 |
Products named: Livdelzi, TREMFYA, VOWST, SKYRIZI, ENTYVIO, REZDIFFRA.
Industry payments across OH — which companies pay providers there.
